{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:14:18Z","timestamp":1790892858768,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177829","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T10:54:38Z","timestamp":1749293678000},"page":"177829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Therapeutic potential of flavonoids against \u03b1-synuclein aggregation in Parkinson's Disease: Integrative in silico and in vitro analysis"],"prefix":"10.1016","volume":"1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7074-0368","authenticated-orcid":false,"given":"Fereshteh Ramezani","family":"Khorsand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Dabirmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosro","family":"Khajeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177829_bib1","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177829_bib3","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1038\/srep09862","article-title":"Curcumin pyrazole and its derivative (N-(3-Nitrophenylpyrazole) curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of wild type and mutant \u03b1-Synuclein","volume":"5","author":"Ahsan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/1871527318666190319141835","article-title":"Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer's disease","volume":"18","author":"Ali","year":"2019","journal-title":"CNS Neurol. Disord. Targets (Formerly Curr. Drug Targets-CNS Neurol. Disord"},{"key":"10.1016\/j.ejphar.2025.177829_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4939-7816-8_5","article-title":"Generation and characterization of stable \u03b1-Synuclein oligomers","author":"Almandoz-Gil","year":"2018","journal-title":"Amyloid Proteins Methods Protoc"},{"key":"10.1016\/j.ejphar.2025.177829_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep29096","article-title":"In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study","volume":"6","author":"Ami","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1348151","article-title":"Neuroprotective effects of flavonoids: endoplasmic reticulum as the target","volume":"18","author":"Amiri","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177829_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-020-2849-1","article-title":"Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts","volume":"20","author":"Ardah","year":"2020","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.ejphar.2025.177829_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/antiox12020280","article-title":"Neuroprotective potentials of flavonoids: experimental studies and mechanisms of action","volume":"12","author":"Bellavite","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177829_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejphar.2025.177829_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.666585","article-title":"\u03b1-Synuclein: an all-inclusive trip around its structure, influencing factors and applied techniques","volume":"9","author":"Bisi","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejphar.2025.177829_bib18","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1111\/febs.12471","article-title":"\u03b1\u2010Synuclein as an intrinsically disordered monomer\u2013fact or artefact?","volume":"280","author":"Coelho\u2010Cerqueira","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2025.177829_bib19","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed In Vitro from \u03b1-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.177829_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","article-title":"Structural characteristics of \u03b1-synuclein oligomers","volume":"329","author":"Cremades","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.177829_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/ijms25021135","article-title":"The 75\u201399 C-Terminal peptide of URG7 protein promotes \u03b1-Synuclein disaggregation","volume":"25","author":"Dandurand","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib24","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejphar.2025.177829_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrep.2015.07.019","article-title":"Transthyretin chemical chaperoning by flavonoids: structure\u2013Activity insights towards the design of potent amyloidosis inhibitors","volume":"3","author":"Ferreira","year":"2015","journal-title":"Biochem. Biophys. Reports"},{"key":"10.1016\/j.ejphar.2025.177829_bib26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177829_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/187152711794480384","article-title":"Flavones from root of Scutellaria baicalensis georgi: drugs of the future in neurodegeneration?","volume":"10","author":"Gasiorowski","year":"2011","journal-title":"CNS Neurol. Disord. Targets (Formerly Curr. Drug Targets-CNS Neurol. Disord"},{"key":"10.1016\/j.ejphar.2025.177829_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbapap.2017.02.014","article-title":"Polyphenols in combination with \u03b2-cyclodextrin can inhibit and disaggregate \u03b1-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative","volume":"1865","author":"Gautam","year":"2017","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejphar.2025.177829_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/cells13030253","article-title":"Characterization of pSer129-\u03b1Syn pathology and neurofilament light-chain release across in vivo, Ex vivo, and in vitro models of pre-formed-fibril-induced \u03b1Syn aggregation","volume":"13","author":"Hansen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177829_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217801","article-title":"The interaction of several herbal extracts with \u03b1-synuclein: fibril formation and surface plasmon resonance analysis","volume":"14","author":"Honarmand","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177829_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140951","article-title":"Effect of flavonoids on the destabilization of \u03b1-synuclein fibrils and their conversion to amorphous aggregate: a molecular dynamics simulation and experimental study","volume":"1871","author":"Jahan","year":"2023","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejphar.2025.177829_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2010.06752.x","article-title":"Baicalein reduces E46K \u03b1\u2010synuclein aggregation In Vitro and protects cells against E46K \u03b1\u2010synuclein toxicity in cell models of familiar parkinsonism","volume":"114","author":"Jiang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177829_bib40","doi-asserted-by":"crossref","first-page":"10306","DOI":"10.1021\/acsomega.1c00655","article-title":"Hydroxyl groups on annular ring-B dictate the affinities of flavonol\u2013CCL2 chemokine binding interactions","volume":"6","author":"Joshi","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2025.177829_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285965","article-title":"Comprehensive In Silico analyses of flavonoids elucidating the drug properties against kidney disease by targeting AIM2","volume":"18","author":"Kandeel","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177829_bib42","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.3390\/molecules27196374","article-title":"In Silico evaluation of natural flavonoids as a potential inhibitor of coronavirus disease","volume":"27","author":"Kashyap","year":"2022","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejphar.2025.177829_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.pmbts.2024.03.015","article-title":"Factors influencing amyloid fibril formation","volume":"206","author":"Khorsand","year":"2024","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.pmbts.2024.03.006","article-title":"Liquid-liquid phase separation as triggering factor of fibril formation","volume":"206","author":"Khorsand","year":"2024","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41531-017-0015-3","article-title":"Integrated molecular landscape of Parkinson's disease","volume":"3","author":"Klemann","year":"2017","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.ejphar.2025.177829_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177829_bib49","author":"Laskowski"},{"key":"10.1016\/j.ejphar.2025.177829_bib54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/ijms24021436","article-title":"\u03b1-Synuclein induces neuroinflammation injury through the IL6ST-AS\/STAT3\/HIF-1\u03b1 axis","volume":"24","author":"Lin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib56","article-title":"Human \u03b14\u03b22 nicotinic acetylcholine receptor as A novel target of oligomeric \u03b1-Synuclein","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177829_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92135-w","article-title":"Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability","volume":"11","author":"Lo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib58","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acschemneuro.3c00162","article-title":"Mechanistic insights into polyphenols' aggregation inhibition of \u03b1-synuclein and related peptides","volume":"14","author":"Martins","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177829_bib60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/molecules22060869","article-title":"In Silico study and bioprospection of the antibacterial and antioxidant effects of flavone and its hydroxylated derivatives","volume":"22","author":"Montenegro","year":"2017","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejphar.2025.177829_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2025.177829_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2022.103458","article-title":"Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19","volume":"29","author":"Mun","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib64","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.3390\/molecules28227618","article-title":"Electrochemistry of flavonoids","volume":"28","author":"Nar\u00f3g","year":"2023","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejphar.2025.177829_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejphar.2025.177829_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2017.11.008","article-title":"Role of hydroxyl groups in the B-ring of flavonoids in stabilization of the hoogsteen paired third strand of poly (U). Poly (A)\u2217 poly (U) triplex","volume":"637","author":"Pradhan","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2025.177829_bib69","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/ijms18030478","article-title":"High-throughput screening methodology to identify alpha-synuclein aggregation inhibitors","volume":"18","author":"Pujols","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib72","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/molecules26051307","article-title":"Suppressing Cdk5 activity by luteolin inhibits MPP+-Induced apoptotic of neuroblastoma through Erk\/Drp1 and Fak\/Akt\/GSK3\u03b2 pathways","volume":"26","author":"Reudhabibadh","year":"2021","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejphar.2025.177829_bib76","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.sbi.2006.01.011","article-title":"Protein aggregation and amyloidosis: confusion of the kinds?","volume":"16","author":"Rousseau","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejphar.2025.177829_bib79","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/ci800305f","article-title":"OSIRIS, an entirely in-house developed drug discovery informatics system","volume":"49","author":"Sander","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2025.177829_bib80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms25010360","article-title":"Alpha-synuclein contribution to neuronal and glial damage in Parkinson's disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184483","article-title":"A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties","volume":"12","author":"Sashourpour","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177829_bib83","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.bbapap.2014.09.007","article-title":"Solution conditions define morphological homogeneity of \u03b1-synuclein fibrils","volume":"1844","author":"Sidhu","year":"2014","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejphar.2025.177829_bib85","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1038\/s41598-017-07800-w","article-title":"Rapid and accurate In Silico solubility screening of a monoclonal antibody library","volume":"7","author":"Sormanni","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0007114507798938","article-title":"Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research","volume":"99","author":"Spencer","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2025.177829_bib87","doi-asserted-by":"crossref","first-page":"24891","DOI":"10.1021\/acsomega.1c03736","article-title":"Theoretical studies on the molecular properties, toxicity, and biological efficacy of 21 new chemical entities","volume":"6","author":"Srivastava","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2025.177829_bib88","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: the interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib89","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1021\/acs.biochem.0c00725","article-title":"Purification of recombinant \u03b1-synuclein: a comparison of commonly used protocols","volume":"59","author":"Stephens","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.177829_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"bmj"},{"key":"10.1016\/j.ejphar.2025.177829_bib91","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177829_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson's disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ejphar.2025.177829_bib93","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1038\/s41467-022-32687-1","article-title":"Single residue modulators of amyloid formation in the N-terminal P1-region of \u03b1-synuclein","volume":"13","author":"Ulamec","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177829_bib94","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human \u03b1-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177829_bib95","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/ci200454v","article-title":"Combining global and local measures for structure-based druggability predictions","volume":"52","author":"Volkamer","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2025.177829_bib97","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.177829_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/srep38510","article-title":"Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel In Vitro assay and an In Vivo drosophila synucleinopathy model","volume":"6","author":"Yedlapudi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177829_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117745","article-title":"Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model","volume":"253","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177829_bib103","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/etm.2014.1564","article-title":"Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-\u03baB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells","volume":"7","author":"Zhu","year":"2014","journal-title":"Exp. Ther. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:19:13Z","timestamp":1778876353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"alternative-id":["S0014299925005837"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177829","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of flavonoids against \u03b1-synuclein aggregation in Parkinson's Disease: Integrative in silico and in vitro analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177829"}}